Nanomaterials demonstrate enormous potential applications in various scientific and
engineering fields due to their unique physical and chemical properties. With the rapid …

Neuromyelitis optica (NMO) spectrum disorder (NMOSD) is a relapsing inflammatory
disease of the CNS, characterized by the presence of serum aquaporin 4 (AQP4) …

Timely screening of neuromyelitis optica spectrum disorder (NMOSD) and differential
diagnosis from myelin oligodendrocyte glycoprotein associated disorder (MOGAD) are the …

Chimeric antigen receptor (CAR) T-cell therapy that targets B-cell maturation antigen
(BCMA) have great potentials in autoimmune diseases and could be novel therapeutics for …

Importance Immunoglobulin G autoantibodies for aquaporin 4 (AQP4-IgG) serve as
diagnostic biomarkers for neuromyelitis optica spectrum disorder (NMOSD), and the most …

Cumulative evidence along several lines indicates that B cells play an important role in the
pathological course of multiple sclerosis (MS), neuromyelitisoptica spectrum disorders …

Inebilizumab (Uplizna®) is a recently approved monoclonal antibody for use in adults with
neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody …

Since the discovery of a specific autoantibody in patients with neuromyelitis optica spectrum
disorder (NMOSD) in 2004, the water channel aquaporin-4 (AQP4) has attracted attention as …

Autoantibodies against myelin oligodendrocyte glycoprotein (MOG) have recently been
established to define a new disease entity, MOG-antibody-associated disease (MOGAD) …

Chimeric antigen receptor (CAR) T cell immunotherapy for the treatment of neurological
autoimmune diseases is promising, but CAR T cell kinetics and immune alterations after …